1-7 of 7
Elena Pentsova
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma

Christian Grommes, Subhiksha Nandakumar, Lauren R. Schaff, Igor Gavrilovic, Thomas J. Kaley, Craig P. Nolan, Jacqueline Stone, Alissa A. Thomas, Sarah S. Tang, Julia Wolfe, Alexis Bozza, Venissala Wongchai, Alisson Hyde, Emma Barrett, Elizabeth A. Lynch, Juli T. Madzsar, Andrew Lin, Anna F. Piotrowski, Elena Pentsova, Jasmine H. Francis, Vaios Hatzoglou, Nikolaus Schultz, Anne S. Reiner, Katherine S. Panageas, Lisa M. DeAngelis, Ingo K. Mellinghoff
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (18): 4005–4015.
https://doi.org/10.1158/1078-0432.CCR-24-0605
Published: 13 September 2024
View articletitled, A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma
Open the PDF for A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma in another window
Includes: Supplementary data
Journal Articles

Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases

N. Ari Wijetunga, Alexander G. Goglia, Nils Weinhold, Michael F. Berger, Michael Cislo, Daniel S. Higginson, Kiana Chabot, Ahmed M. Osman, Lauren Schaff, Elena Pentsova, Alexandra M. Miller, Simon N. Powell, Adrienne Boire, Jonathan T. Yang
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (4): 775–783.
https://doi.org/10.1158/1078-0432.CCR-22-2434
Published: 16 February 2023
View articletitled, Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases
Open the PDF for Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases in another window
Includes: Supplementary data
Journal Articles

Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas

Philip Jonsson, Andrew L. Lin, Robert J. Young, Natalie M. DiStefano, David M. Hyman, Bob T. Li, Michael F. Berger, Ahmet Zehir, Marc Ladanyi, David B. Solit, Angela G. Arnold, Zsofia K. Stadler, Diana Mandelker, Michael E. Goldberg, Juliann Chmielecki, Maryam Pourmaleki, Shahiba Q. Ogilvie, Shweta S. Chavan, Andrew T. McKeown, Malbora Manne, Allison Hyde, Kathryn Beal, T. Jonathan Yang, Craig P. Nolan, Elena Pentsova, Antonio Omuro, Igor T. Gavrilovic, Thomas J. Kaley, Eli L. Diamond, Jacqueline B. Stone, Christian Grommes, Adrienne Boire, Mariza Daras, Anna F. Piotrowski, Alexandra M. Miller, Philip H. Gutin, Timothy A. Chan, Viviane S. Tabar, Cameron W. Brennan, Marc Rosenblum, Lisa M. DeAngelis, Ingo K. Mellinghoff, Barry S. Taylor
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (18): 5537–5547.
https://doi.org/10.1158/1078-0432.CCR-19-0032
Published: 13 September 2019
View articletitled, Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas
Open the PDF for Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases

Aki Morikawa, Elisa de Stanchina, Elena Pentsova, Margaret M. Kemeny, Bob T. Li, Kendrick Tang, Sujata Patil, Martin Fleisher, Catherine Van Poznak, Larry Norton, Andrew D. Seidman
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (13): 3784–3792.
https://doi.org/10.1158/1078-0432.CCR-18-3502
Published: 01 July 2019
View articletitled, Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases
Open the PDF for Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases in another window
Includes: Supplementary data
Journal Articles

Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial

Ran Xu, Fumiko Shimizu, Koos Hovinga, Kathryn Beal, Sasan Karimi, Leif Droms, Kyung K. Peck, Philip Gutin, J. Bryan Iorgulescu, Thomas Kaley, Lisa DeAngelis, Elena Pentsova, Craig Nolan, Christian Grommes, Timothy Chan, Dylan Bobrow, Adilia Hormigo, Justin R. Cross, Nian Wu, Naoko Takebe, Katherine Panageas, Percy Ivy, Jeffrey G. Supko, Viviane Tabar, Antonio Omuro
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (19): 4786–4796.
https://doi.org/10.1158/1078-0432.CCR-16-0048
Published: 02 October 2016
View articletitled, Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial
Open the PDF for Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma

Antonio Omuro, Kathryn Beal, Philip Gutin, Sasan Karimi, Denise D. Correa, Thomas J. Kaley, Lisa M. DeAngelis, Timothy A. Chan, Igor T. Gavrilovic, Craig Nolan, Adilia Hormigo, Andrew B. Lassman, Ingo Mellinghoff, Christian Grommes, Anne S. Reiner, Katherine S. Panageas, Raymond E. Baser, Viviane Tabar, Elena Pentsova, Juan Sanchez, Renata Barradas-Panchal, Jianan Zhang, Geraldine Faivre, Cameron W. Brennan, Lauren E. Abrey, Jason T. Huse
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (19): 5023–5031.
https://doi.org/10.1158/1078-0432.CCR-14-0822
Published: 30 September 2014
View articletitled, Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
Open the PDF for Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma in another window
Includes: Supplementary data
Journal Articles

IDH Mutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower Grade Diffuse Astrocytic Glioma

Daniel Gorovets, Kasthuri Kannan, Ronglai Shen, Edward R. Kastenhuber, Nasrin Islamdoust, Carl Campos, Elena Pentsova, Adriana Heguy, Suresh C. Jhanwar, Ingo K. Mellinghoff, Timothy A. Chan, Jason T. Huse
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (9): 2490–2501.
https://doi.org/10.1158/1078-0432.CCR-11-2977
Published: 30 April 2012
View articletitled, IDH Mutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower Grade Diffuse Astrocytic Glioma
Open the PDF for IDH Mutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower Grade Diffuse Astrocytic Glioma in another window
Includes: Supplementary data